Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR)

European Journal of Endocrinology

Volumn 136, Issue 1, 1997, Pages 61-66

  Fisker, Sanne ^a   Kaal, Andreas ^a   Montini, Marcella ^b   Pedroncelli, Alberto ^b   Pagani, Giorgio ^b   Ørskov, Hans ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rioniti Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; OCTREOTIDE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MALE; PLASMA CLEARANCE; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031054714     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360061     Document Type: Article

References (44)

1. Herington AC, Ymer S & Stevenson J. Identification and characterization of specific binding proteins for growth hormone in normal human sera. Journal of Clinical Investigation 1986 77 1817-1823.
2. Baumann G, Stolar MW, Amburn K, Barsano CP & DeVries BC. A specific growth hormone-binding protein in human plasma: initial characterization. Journal of Clinical Endocrinology and Metabolism 1986 62 134-141.
3. Hocquette JF, Postel Vinay MC, Djiane J, Tar A & Kelly PA. Human liver growth hormone receptor and plasma binding protein: characterization and partial purification. Endocrinology 1990 127 1665-1672.
4. Sotiropoulos A, Goujon L, Simonin G, Kelly PA, Postel Vinay MC & Finidori J. Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology 1993 132 1863-1865.
5. Mercado M, Molitch ME & Baumann G. Low plasma growth hormone binding protein in IDDM. Diabetes 1992 41 605-609.
6. Menon RK, Arslanian S, May B, Cutfield WS & Sperling MA. Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1992 74 934-938.
7. Holl RW, Siegler B, Scherbaum WA & Heinze E. The serum growth hormone-binding protein is reduced in young patients with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1993 76 165-167.
8. Martha PMJ, Rogol AD, Carlsson LM, Gesundheit N & Blizzard RM. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. I. Serum growth hormone-binding protein. Journal of Clinical Endocrinology and Metabolism 1993 77 452-457.
9. Martha PMJ, Reiter EO, Davila N, Shaw MA, Holcombe JH & Baumann G. Serum growth hormone (GH)-binding protein/ receptor: an important determinant of GH responsiveness. Journal of Clinical Endocrinology and Metabolism 1992 75 1464-1469.
10. van Teunenbroek A, de Muinck Keizer Schrama SM, Stijnen T, Mouton JW, Blum WF, Mercado M et al. Effect of growth hormone administration frequency on 24-h growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone. Clinical Endocrinology 1993 39 77-84.
11. Tauber M, De Bouet Du Portal H, Sallerin Caute B, Rochiecioli P & Bastide R. Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children. Journal of Clinical Endocrinology and Metabolism 1993 76 1135-1139.
12. Ho KK, Valiontis E, Waters MJ & Rajkovic IA. Regulation of growth hormone binding protein in man: comparison of gel chromatography and immunoprecipitation methods. Journal of Clinical Endocrinology and Metabolism 1993 76 302-308.
13. Ho KK, Jorgensen JO, Valiontis E, Waters MJ, Rajkovic IA & Christiansen JS. Different modes of growth hormone (GH) administration do not change GH binding protein activity in man. Clinical Endocrinology 1993 38 143-148.
14. Roelen CA, Donker GH, Thijssen JH, Koppeschaar HP & Blankenstein MA. High affinity growth hormone binding protein in plasma of patients with acromegaly and the effect of octreotide treatment. Clinical Endocrinology 1992 37 373-378.
15. Mandel S, Moreland E, Nichols V, Hanna C & Lafranchi S. Changes in insulin-like growth factor-I (IGF-I). IGF-binding protein-3. growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment. Journal of Clinical Endocrinology and Metabolism 1995 80 190-194.
16. Kratzsch J, Blum VVF, Ventz M, Selisko T, Birkenmeyer G & Keller E. Growth hormone-binding protein-related immunoreactivity in the serum of patients with acromegaly is regulated inversely by growth hormone concentration. European Journal of Endocrinology 1995 132 306-312.
17. Johannsson G, Bjarnason R, Bramnert M, Carlsson LMS, Degerblad M, Manhem P et al. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. Journal of Clinical Endocrinology and Metabolism 1996 81 1575-1581.
18. Page MD, Millward ME, Taylor A, Preecc M, Hourihan M, Hall R et al. Long-term treatment of acromegaly with a long-acting analogue of somatostatin, octreotide. Quarterly Journal of Medicine 1990 74 189-201.
19. Page MD, Millward ME, Hourihan M, Hall R & Scanlon NF. Long-term treatment of acromegaly with octreotide (Sandostatin). Hormone Research 1990 33 Suppl 1 20-30.
20. Lancranjan I, Bruns C, Grass P, Jaquet P, Jervell J, Kendall-Taylor P et al. Sandostatin LAR: Pharmacokinetics, pharmacodynainics, efficacy, and tolerability in acromegalic patients. Metabolism 1995 44(Suppl) 18-26.
21. Kaal A, Frystyk J, Skjœrbœk C, Nielsen S, Jørgensen JOL, Bruns C et al. Effects of intramuscular microsphere-encapsulated octreotide on serum growth hormone, insulin-like growth hormone factors (IGFs), free IGFs, and IGF-binding proteins in acromegalic patients. Metabolism 1995 44 (Suppl) 6-14.
22. Fisker S, Frystyk J, Skriver L, Vestbo E, Ho KKY & Ørskov H. A simple, rapid immunometric assay for determination of functional and growth hormone (GH)-occupied GH-binding protein in human serum. European Journal of Clinical Investigation 1996 26 779-785.
23. Frystyk J, Dinesen B & Ørskov H. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regulation 1995 5 169-176.
24. Amit T, Ish Shalom S, Glaser B, Youdim MB & Hochberg Z. Growth-hormone-binding protein in patients with acromegaly. Hormone Research 1992 37 205-211.
25. Carlsson LM, Rosberg S, Vitangcol RV. Wong WL & Albertsson Wikland K. Analysis of 24-h plasma profiles of growth hormone (GH)-binding protein, GH/GH-binding protein-complex, and GH in healthy children. Journal of Clinical Endocrinology and Metabolism 1993 77 356-361.
26. Rajkovic IA, Valiontis E & Ho KK. Direct quantitation of growth hormone binding protein in human serum by a ligand immunofunctional assay: comparison with immunoprecipitation and Chromatographic methods. Journal of Clinical Endocrinology and Metabolism 1994 78 772-777.
27. Luthman M, Stock S, Werner S & Bremme K. Growth hormone-binding protein in plasma is inversely correlated to placental lactogen and augmented with increasing body mass index in healthy pregnant women and women with gestational diabetes mellitus. Gynecological and Obstetric Investigation 1994 38 145-150.
28. Martha PMJ, Reiter EO, Davila N, Shaw MA, Holcombe JH & Baumann G. The role of body mass in the response to growth hormone therapy. Journal of Clinical Endocrinology and Metabolism 1992 75 1470-1473.
29. Martha PMJ, Rogol AD, Blizzard RM, Shaw MA & Baumann G. Growth hormone-binding protein activity is inversely related to 24-h growth hormone release in normal boys. Journal of Clinical Endocrinology and Metabolism 1991 73 175-181.
30. Hattori N, Kurahachi H, Ikekubo K, Ishihara T, Moridera K, Hino M et al. Effects of sex and age on serum GH binding protein levels in normal adults. Clinical Endocrinology 1991 35 295-297.
31. Rosenfeld RG. Circulating growth hormone binding proteins. Hormone Research 1994 42 129-132.
32. Harrison SM, Barnard R, Ho KY, Rajkovic I & Waters MJ. Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor. Endocrinology 1995 136 651-659.
33. Baumann G, Shaw MA & Buchanan TA. In vivo kinetics of a covalent growth hormone-binding protein complex. Metabolism 1989 38 330-333.
34. Dattani MT, Hindmarsh PC, Brook CG, Robinson IC & Marshall NJ. Inhibition of growth hormone bioactivity by recombinant human growth hormone-binding protein in the eluted stain assay system. Journal of Endocrinology 1994 140 445-453.
35. Baumbach WR, Horner DL & Logan JS. The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes and Development 1989 3 1199-1205.
36. Counts DR, Gwirtsman H, Carlsson LM, Lesern M & Cutler GBJ. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. Journal of Clinical Endocrinology and Metabolism 1992 75 762-767.
37. Jørgensen JO, Pedersen SB, Børglum J, Frystyk J, Ho KK, Christiansen JS et al. Serum concentrations of insulin-like growth factors (IGFs). IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study. European Journal of Endocrinology 1995 133 65-70.
38. Hochberg Z, Hertz P, Colin V, Ish Shalom S, Yeshurun D, Youdim MB et al. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I). and IGF-I receptors in obesity and anorexia nervosa. Metabolism 1992 41 106-112.
39. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML & Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. Journal of Clinical Endocrinology and Metabolism 1991 72 51-59.
40. Glass AR, Burman KD, Dahms WT & Boehm TM, Endocrine function in human obesity. Metabolism 1981 30 89-104.
41. Meistas MT, Foster GV, Margolis S & Kowarski AA. Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity. Metabolism 1982 31 1224-1228.
42. Ho PJ, Gesundheit N, Wong WL, Huang SH, Friberg RD & Barkan AL. Dynamic changes of growth hormone-binding protein concentrations in normal men and patients with acromegaly: effects of short-term fasting. Metabolism 1995 44 667-672.
43. Baumann G, Shaw MA & Amburn K. Regulation of plasma growth hormone-binding proteins in health and disease. Metabolism 1989 38 683-689.
44. Mercado M, Carlsson L, Vitangcol R & Baumann G. Growth hormone-binding protein determination in plasma: a comparison of immunofunctional and growth hormone-binding assays. Journal of Clinical Endocrinology and Metabolism 1993 76 1291-1294.